Jay Olson
Stock Analyst at Oppenheimer
(4.89)
# 286
Out of 4,468 analysts
1161
Total ratings
50.7%
Success rate
26.5%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Initiated Coverage: Buy | $24.17 | $9.45 | +155.79% | 1 | Jun 26, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | $10 | $1.45 | +589.66% | 5 | Jun 22, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $40 → $60 | $44.19 | +35.78% | 6 | Jun 22, 2026 | |
| APRE Aprea Therapeutics | Initiated Coverage: Buy | $5 | $0.741 | +574.76% | 1 | Jun 15, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Initiated Coverage: Buy | $9 | $4.46 | +101.79% | 1 | Jun 15, 2026 | |
| INCY Incyte | Maintained: Hold | $90 → $107 | $116.86 | -8.44% | 82 | Jun 8, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $750 → $650 | $318.52 | +104.07% | 6 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $165 → $195 | $189.24 | +3.04% | 24 | Jun 1, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $32 | $9.49 | +237.20% | 1 | May 28, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $40 | $25.83 | +54.86% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $71.04 | +97.07% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $192 → $230 | $174.26 | +31.99% | 89 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $528.04 | +13.63% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $33 | $7.61 | +333.64% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $55.85 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $97.55 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.68 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.62 | +46.84% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $72 | $37.26 | +93.24% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $79.76 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $5.19 | +208.29% | 4 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $2.02 | +395.05% | 5 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $275 | $216.12 | +27.24% | 98 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $36 | $4.35 | +727.59% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.09 | +52.79% | 8 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.7005 | +1,327.55% | 14 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $5.19 | +478.03% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $25.10 | +139.04% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 | $528.10 | +23.08% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $380 → $400 | $374.15 | +6.91% | 83 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.68 | +257.14% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.69 | +160.22% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $27 | $17.56 | +53.76% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $81.80 | +10.02% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $37.44 | +167.09% | 38 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.91 | +318.85% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.78 | +376.19% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.70 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $0.4283 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $30.43 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $131.27 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $15.11 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $25.97 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $60.08 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.65 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.17 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $10 | $29.98 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.22 | n/a | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.95 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.00 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $6.28 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.10 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.09 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 8 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $2.11 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $7 | $15.17 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.03 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.20 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2489 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.06 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.28 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.34 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $0.25 | $4.52 | n/a | 5 | Mar 30, 2016 |
Eupraxia Pharmaceuticals Inc.
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $24.17
Current: $9.45
Upside: +155.79%
Coherus Oncology
Jun 22, 2026
Reiterated: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Definium Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $40 → $60
Current: $44.19
Upside: +35.78%
Aprea Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.741
Upside: +574.76%
Zentalis Pharmaceuticals
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $4.46
Upside: +101.79%
Incyte
Jun 8, 2026
Maintained: Hold
Price Target: $90 → $107
Current: $116.86
Upside: -8.44%
Praxis Precision Medicines
Jun 2, 2026
Rated: Buy
Price Target: $750 → $650
Current: $318.52
Upside: +104.07%
Revolution Medicines
Jun 1, 2026
Rated: Buy
Price Target: $165 → $195
Current: $189.24
Upside: +3.04%
Adlai Nortye
May 28, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $9.49
Upside: +237.20%
Denali Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $25.83
Upside: +54.86%
May 8, 2026
Maintained: Buy
Price Target: $115 → $140
Current: $71.04
Upside: +97.07%
May 6, 2026
Rated: Buy
Price Target: $192 → $230
Current: $174.26
Upside: +31.99%
May 5, 2026
Maintained: Buy
Price Target: $600
Current: $528.04
Upside: +13.63%
May 1, 2026
Rated: Buy
Price Target: $25 → $33
Current: $7.61
Upside: +333.64%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $55.85
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $97.55
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $4.68
Upside: -
Apr 24, 2026
Maintained: Buy
Price Target: $20
Current: $13.62
Upside: +46.84%
Apr 22, 2026
Maintained: Buy
Price Target: $61 → $72
Current: $37.26
Upside: +93.24%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $79.76
Upside: -
Apr 5, 2026
Rated: Buy
Price Target: $16
Current: $5.19
Upside: +208.29%
Apr 2, 2026
Rated: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
Apr 1, 2026
Rated: Buy
Price Target: $250 → $275
Current: $216.12
Upside: +27.24%
Mar 18, 2026
Maintained: Buy
Price Target: $44 → $36
Current: $4.35
Upside: +727.59%
Mar 11, 2026
Maintained: Buy
Price Target: $20
Current: $13.09
Upside: +52.79%
Mar 11, 2026
Maintained: Buy
Price Target: $10
Current: $0.7005
Upside: +1,327.55%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $5.19
Upside: +478.03%
Feb 25, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $25.10
Upside: +139.04%
Feb 9, 2026
Maintained: Buy
Price Target: $650
Current: $528.10
Upside: +23.08%
Jan 29, 2026
Maintained: Buy
Price Target: $380 → $400
Current: $374.15
Upside: +6.91%
Nov 13, 2025
Maintained: Buy
Price Target: $6
Current: $1.68
Upside: +257.14%
Nov 13, 2025
Maintained: Buy
Price Target: $7
Current: $2.69
Upside: +160.22%
Nov 7, 2025
Maintained: Buy
Price Target: $40 → $27
Current: $17.56
Upside: +53.76%
Oct 27, 2025
Maintained: Buy
Price Target: $90
Current: $81.80
Upside: +10.02%
Oct 7, 2025
Maintained: Buy
Price Target: $100
Current: $37.44
Upside: +167.09%
Oct 7, 2025
Maintained: Buy
Price Target: $8
Current: $1.91
Upside: +318.85%
Oct 2, 2025
Maintained: Buy
Price Target: $18
Current: $3.78
Upside: +376.19%
Jun 16, 2025
Maintained: Hold
Price Target: n/a
Current: $9.70
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $65
Current: $0.4283
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $30.43
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $131.27
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $14
Current: $15.11
Upside: n/a
Nov 8, 2024
Maintained: Hold
Price Target: $17
Current: $25.97
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $95
Current: $60.08
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $3.65
Upside: n/a
Nov 4, 2024
Maintained: Buy
Price Target: $9
Current: $1.17
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $9 → $10
Current: $29.98
Upside: n/a
Aug 12, 2024
Maintained: Buy
Price Target: $33
Current: $1.22
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.95
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $14.00
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $6.28
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $11.10
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $1.09
Upside: n/a
May 8, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 22, 2019
Maintained: Buy
Price Target: $10 → $9
Current: $2.11
Upside: n/a
Aug 14, 2019
Maintained: Buy
Price Target: $15 → $7
Current: $15.17
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.03
Upside: n/a
Mar 24, 2019
Maintained: Buy
Price Target: n/a
Current: $2.20
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.2489
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $4.06
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $7.28
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $12.34
Upside: n/a
Mar 30, 2016
Maintained: Sell
Price Target: $2 → $0.25
Current: $4.52
Upside: n/a